Department of Cardiology, Bağcılar Training and Research Hospital, Bağcılar, İstanbul, Turkey.
Department of Cardiovascular Surgery, Bağcılar Training and Research Hospital, Bağcılar, İstanbul, Turkey.
Braz J Cardiovasc Surg. 2023 Jul 4;38(4):e20220355. doi: 10.21470/1678-9741-2022-0355.
The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II and the Society of Thoracic Surgeons (STS) are validated scoring systems for short-term risk estimation after coronary artery bypass grafting (CABG). The Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score is originally aimed to estimate mortality in heart failure patients; however, it has showed a similar power to predict mortality after heart valve surgery. In this study, we sought to evaluate whether MAGGIC score may predict short and long-term mortality after CABG and to compare its power with EuroSCORE II and STS scoring systems.
Patients who underwent CABG due to chronic coronary syndrome at our institution were included in this retrospective study. Follow-up data were used to define the predictive ability of MAGGIC and to compare it with STS and EuroSCORE-II for early, one-year, and up to 10-year mortality.
MAGGIC, STS, and EuroSCORE-II scores had good prognostic power, moreover MAGGIC was better for predicting 30-day (area under the curve [AUC]: 0.903; 95% confidence interval [CI]: 0.871-0.935), one-year (AUC: 0.931; 95% CI: 0.907-0.955), and 10-year (AUC: 0.923; 95% CI: 0.893-0.954) mortality. MAGGIC was found to be an independent predictor to sustain statistically significant association with mortality in follow-up.
MAGGIC scoring system had a good predictive accuracy for early and long-term mortality in patients undergoing CABG when compared to EuroSCORE-II and STS scores. It requires limited variables for calculation and still yields better prognostic power in determining 30-day, one-year, and up to 10-year mortality.
欧洲心脏手术风险评估系统(EuroSCORE)II 和胸外科医师学会(STS)是经验证的用于评估冠状动脉旁路移植术(CABG)后短期风险的评分系统。Meta 分析全球慢性心力衰竭组(MAGGIC)风险评分最初旨在评估心力衰竭患者的死亡率;然而,它在预测心脏瓣膜手术后死亡率方面显示出相似的效力。在这项研究中,我们试图评估 MAGGIC 评分是否可以预测 CABG 后的短期和长期死亡率,并比较其与 EuroSCORE II 和 STS 评分系统的效能。
我们的机构对因慢性冠状动脉综合征而接受 CABG 的患者进行了这项回顾性研究。随访数据用于定义 MAGGIC 的预测能力,并将其与 STS 和 EuroSCORE-II 进行比较,以评估其对早期、一年和长达 10 年死亡率的预测能力。
MAGGIC、STS 和 EuroSCORE-II 评分具有良好的预后能力,此外,MAGGIC 更适合预测 30 天(曲线下面积 [AUC]:0.903;95%置信区间 [CI]:0.871-0.935)、1 年(AUC:0.931;95% CI:0.907-0.955)和 10 年(AUC:0.923;95% CI:0.893-0.954)死亡率。MAGGIC 被发现是与随访期间死亡率持续具有统计学显著关联的独立预测因素。
与 EuroSCORE-II 和 STS 评分相比,MAGGIC 评分系统在预测 CABG 患者的早期和长期死亡率方面具有良好的预测准确性。它的计算所需变量有限,但在确定 30 天、1 年和长达 10 年死亡率方面仍具有更好的预后能力。